2025
DOI: 10.5306/wjco.v16.i2.97823
|View full text |Cite
|
Sign up to set email alerts
|

Pembrolizumab-induced Guillain-Barré syndrome in triple-negative breast cancer: A case report

Phani Bhavana Cherukuri,
Muhammad Tayyeb,
Sai Rakshith Gaddameedi
et al.

Abstract: BACKGROUND The programmed cell death protein 1 inhibitor pembrolizumab has become a key treatment for various cancers, including triple-negative breast cancer. However, it is associated with immune-related adverse events, including rare but serious neurological complications such as Guillain-Barré syndrome (GBS). GBS is a potentially life-threatening autoimmune disorder characterized by muscle weakness and paralysis. We present a unique case of pembrolizumab-induced GBS to highlight the importance of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 27 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?